Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (271-280 of 492) with videos related to

Pageof 50
Sort By:
Leukemia Research|June 15, 2010
Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment sizeJ Nomdedeu, E Bussaglia, N Villamor, et al.
Leukemia Research|August 13, 2005
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patientsG Perea, A Domingo, N Villamor, et al.
Leukemia|June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapyD Martínez-Cuadrón, P Montesinos, E Vellenga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow TransplantationJ Sierra, S Brunet, A Grañena, et al.
British Journal of Haematology|September 21, 2001
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantationD Gallardo, J I Aróstegui, A Balas, et al.
Leukemia|November 11, 2005
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]G Perea, A Lasa, A Aventín, et al.
Leukemia|January 13, 2006
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patientsJ A Pérez-Simón, A Sureda, F Fernández-Aviles, et al.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Pageof 50

Showing results (271-280 of 492) with videos related to

Sort By:
Pageof 50
Leukemia Research|June 15, 2010
Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment sizeJ Nomdedeu, E Bussaglia, N Villamor, et al.
Leukemia Research|August 13, 2005
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patientsG Perea, A Domingo, N Villamor, et al.
Leukemia|June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapyD Martínez-Cuadrón, P Montesinos, E Vellenga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow TransplantationJ Sierra, S Brunet, A Grañena, et al.
British Journal of Haematology|September 21, 2001
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantationD Gallardo, J I Aróstegui, A Balas, et al.
Leukemia|November 11, 2005
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]G Perea, A Lasa, A Aventín, et al.
Leukemia|January 13, 2006
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patientsJ A Pérez-Simón, A Sureda, F Fernández-Aviles, et al.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Pageof 50